3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow NMIBC: new trials by email Literature Review of NMIBC trials Research Report on NMIBC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer ZH9 - NMIBC, High Risk NMIBC | Phase 1 | Completed | Prokarium Ltd | 22 | 2024-01-08 | 2026-10-14 |
| A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) UGN-301, UGN-201, Gemcitabine - Non-muscle Invasive Bladder Cancer, NMIBC | Phase 1 | Completed | UroGen Pharma Ltd. | 51 | 2022-06-01 | 2026-01-14 |
| A Phase I-II Study of Novel Oncolytic Virus VG161 Via Intravesical Instillation for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer VG161 via Intravesical Instillation - NMIBC | Phase 1 / Phase 2 | Completed | Ding-Wei Ye | 20 | 2021-10-12 | 2026-04-01 |
Non-Muscle Invasive Bladder Neoplasms (3) · Urinary Bladder Neoplasms (1)
Carcinoma (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Glandular and Epithelial (3) · Urinary Bladder Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Urologic Diseases (3) · Urologic Neoplasms (3) · Urinary Bladder Neoplasms (2)
Gemcitabine (1) · Imiquimod (1)
Ding-Wei Ye (1) · Prokarium Ltd (1) · UroGen Pharma Ltd. (1)
United States (2) · China (1) · Italy (1) · Spain (1)
Josefin-Beate Holz, MD (1) · Sebastian Mirkin, MD (1)